Document is current
Any future updates will be listed below
-
Authors
Krings, Amrei
Kollan, Christian
Schmidt, Daniel
Gunsenheimer-Bartmeyer, Barbara
Valbert, Frederik
Neumann, Anja
Wasem, Jürgen
Behrens, Georg M. N.
Bickel, Markus
Boesecke, Christoph
Esser, Stefan
Dröge, Patrik
Ruhnke, Thomas
Koppe, Uwe
,
Knechten, Heribert
Panstrugart, Petra
Arasteh, Keikawus
Rittweger, Michael
Wesselmann, Hans
Menner, Nikolai
Schürmann, Dirk
Warncke, Marianne
Bohr, Ulrich
Jessen, Heiko
Jessen, Arne B.
Schulbin, Hubert
Brand, Sascha
Gumprecht, Jan
Weninger, Beate
Hillenbrand, Heribert
Karcher, Heiko
Fischer, Klaus
Schranz, Dietmar
Vallée, Mathias
Hartikainen, Jukka
Grunwald, Stephan
Claus, Jörg A.
Thomas, Claudia
Grimm, Roland
Schoor, Sarah
Cordes, Christiane
Schröder, Reinhold
Glaunsinger, Tobias
Rausch, Michael
Reineke, Thomas
Weinberg, Gordon
Bruhy, Manuel
Köppe, Siegfried
Kreckel, Peter
Berger, Andreas
Lindemann, Sinah
Brockmeyer, Norbert H.
Potthoff, Anja
van Bremen, Kathrin
Rockstroh, Jürgen
Wasmuth, Jan-Christian
Hass, Svetlana
Hower, Martin
Bachmann, Claudia
Spornraft-Ragaller, Petra
Teichmann, Dieter
Jensen, Björn-Erik Ole
Hüttig, Falk
Feind, Cecilie
Schenk-Westkamp, Pia
Haberl, Annette
Stephan, Christoph
Schott, Peter
Usadel, Susanne
Müller, Matthias
Trauth, Janina
Chavez-Valladares, Alan
Deutschinoff, Gerd
Kreft, Burkhard
Lange, Danica
Degen, Olaf
Schäfer, Guido
Plettenberg, Andreas
Kuhlendahl, Frieder
Lorenzen, Thore
Wiemer, Dorothea
Biemann, Lavinia
Adam, Axel
Buhk, Thomas
Fenske, Stephan
Hansen, Stefan
Sabranski, Michael
Schewe, Knud
Hoffmann, Christian
Stellbrink, Hans-Jürgen
Radzuweit, Dennis
Mainka, Alexander
Rickassel, Constantin
Degen, Olaf
Schäfer, Guido
Scheiter, Robin
Behrens, Georg
Stoll, Matthias
Gerschmann, Steve
Beider, Renate
Schleenvoigt, Benjamin T.
Pletz, Mathias W.
Horst, Heinz-August
Trautmann, Silke
Rieke, Ansgar
Schneeweiß, Stephan
Scholten, Stefan
Oette, Mark
Fätkenheuer, Gerd
Vehreschild, Jörg Janne
Hamacher, Laura
Nicksch, Lennart
Arbter, Peter A.
Grünewald, Thomas
Weidemann, Jeannine
Ruck, Ines
Claus, Bernd
Sprinzl, Martin
Galle, Peter R.
Ebert, Matthias P.
Vogelmann, Roger
Bogner, Johannes
Hellerer, Ulrike
Sonntag, Barbara
Pullen, Oliver
Todorova, Antoniya
Traidl-Hoffmann, Claudia
Mück, Birgit
Pauli, Ramona
Spinner, Christoph D.
Schneider, Jochen
Mück, Birgit
Baumann, Robert
Schübel, Niels
Berning, Christiane
Audebert, Franz
Fritzsche, Carlos
Trein, A
Schnaitmann, E
Roll, Clemens
Marquardt, Simone
Härter, Georg
Grüner, Beate
Güler, Cengiz
Rößler, Steve
-
Funding
Funding for this research was provided by:
Fund of the Federal Joint Committee (01VSF21050, 01VSF21050, 01VSF21050, 01VSF21050, 01VSF21050, 01VSF21050, 01VSF21050)
Robert Koch-Institut
- License Information
-
More Information
Article History
Received: 5 August 2024
Accepted: 14 October 2024
First Online: 30 October 2024
Declarations
:
: GB: Grants or contracts from Niedersächsisches Ministerium für Wissenschaft und Kultur, COFONI Network, and European Regional Development Fund, consulting fees Gilead, ViiV, MSD, Virology Education, Janssen, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Gilead, ViiV, MSD, Virology Education, Janssen, support for attending meetings and/or travel from DZIF, NEAT ID Foundation, Participation on a Data Safety Monitoring Board or Advisory Board of TherVacB_Phase1a. CB: Grants or contracts from DZIF, DFG and Hector Foundation, consulting fees from Abbvie, Gilead, JnJ, MSD, and ViiV, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Abbvie, Gilead, JnJ, MSD, and ViiV, support for attending meetings and/or travel from Abbvie, Gilead, JnJ, MSD, and ViiV. SE: Grants or contracts from Gilead, Janssen, MSD, and ViiV consulting fees from Gilead, GSK, Janssen, MSD, and ViiV, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Gilead, Janssen, MSD, and ViiV, support for attending meetings and/or travel from Gilead, Janssen, MSD, and ViiV, Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid in DAIG, DAGNÄ, DSTIG, DDG, DGI, Regional commission AIDS NRW. UK: Support for attending meetings and/or travel from ECDC, German AIDS Society, German STI Society, and European AIDS Society; UK owns ‘Exchange-traded fund’ (ETF) shares, which includes stocks of companies that are involved in health care. The remaining authors have no competing interests to declare.
: The HIV-1 Seroconverter Study was approved by the Ethics Committee of the Charité University Medicine Berlin (EA2/024/21). Participants of the HIV-1 Seroconverter Study provide their written informed consent to participate. The ClinSurv-HIV Study data (1999–2018) were collected anonymously and in compliance with the German Infection Protection Act (IfSG, 2001).
: These data did therefore not require written informed consent. Approval for this was granted by the RKI data protection officer and the Federal Commissioner for Data Protection and Freedom of Information.
